KYMR

Kymera Therapeutics, Inc.

Healthcare · USD

Set alert

Price alert · KYMR

All alert types
126.63 USD +4.03 +3.29%
As of Oct 30, 2026 Extended hours 127.00 +0.29%
Bid
126.42 × 2
Ask
126.75 × 2
117.31 Day range 127.26
58.66 52-week range 127.31
YTD
+62.74%
1 year
+106.10%
Open
122.58
Prev close
122.60
Mkt cap
10.81B
Vol
1.59M
Avg vol
757.60K
EPS
-3.64
P/E
0.00
Div yield
0.00%
More statistics
Low
117.31
High
127.26
Forward P/E
-24.89
Beta
0.00
Short ratio
10.32
Inst. own
119.34%
Dividend
0.00
Ex-div date
Earnings
Feb 25, 2027
50-d avg
114.81
200-d avg
96.16
1y target
140.26

5D chart

Chart tools
Interval
KYMR five-day price chart110.3114.7119.0123.4127.7Oct 26Oct 27Oct 28Oct 29Oct 30

Financial health

Altman Z-Score

40.33 Safe zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

4 / 9 Average

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

C-1 / 5 overall

  • DCF 1
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 4
  • P/E 1
  • P/B 1

Valuation

P/E -21.1×
FY 2018: -69.3×FY 2019: -35.8×FY 2020: -62.6×FY 2021: -30.4×FY 2022: -8.7×FY 2023: -10.1×FY 2024: -13.5×FY 2025: -21.1×
FY 2018 5y median -13.5× FY 2025
P/S 168×
FY 2018: 0.0×FY 2019: 505×FY 2020: 81.2×FY 2021: 41.8×FY 2022: 28.7×FY 2023: 18.9×FY 2024: 64.1×FY 2025: 168×
FY 2018 5y median 41.8× FY 2025
P/B 4.2×
FY 2018: -43.0×FY 2019: -19.9×FY 2020: 9.7×FY 2021: 6.6×FY 2022: 2.7×FY 2023: 3.8×FY 2024: 3.6×FY 2025: 4.2×
FY 2018 5y median 3.8× FY 2025
P/FCF -28.0×
FY 2018: -77.1×FY 2019: 85.3×FY 2020: 35.0×FY 2021: -23.3×FY 2022: -8.6×FY 2023: -10.8×FY 2024: -14.6×FY 2025: -28.0×
FY 2018 5y median -14.6× FY 2025
EV/EBITDA -20.8×
FY 2018: -67.8×FY 2019: -35.3×FY 2020: -62.9×FY 2021: -30.9×FY 2022: -8.5×FY 2023: -10.2×FY 2024: -13.8×FY 2025: -20.8×
FY 2018 5y median -13.8× FY 2025
EV/Sales 161×
FY 2018: 0.0×FY 2019: 486×FY 2020: 80.8×FY 2021: 41.4×FY 2022: 27.7×FY 2023: 18.6×FY 2024: 63.4×FY 2025: 161×
FY 2018 5y median 41.4× FY 2025
FCF Yield -3.6%
FY 2018: -1.3%FY 2019: 1.2%FY 2020: 2.9%FY 2021: -4.3%FY 2022: -11.6%FY 2023: -9.2%FY 2024: -6.9%FY 2025: -3.6%
FY 2018 5y median -6.9% FY 2025

Profitability

Gross Margin 100.0%
FY 2018: 0.0%FY 2019: 71.9%FY 2020: 100.0%FY 2021: 100.0%FY 2022: 100.0%FY 2023: 100.0%FY 2024: 100.0%FY 2025: 100.0%
FY 2018 5y median 100.0% FY 2025
Operating Margin -891.3%
FY 2018: 0.0%FY 2019: -1438.5%FY 2020: -136.1%FY 2021: -138.0%FY 2022: -344.4%FY 2023: -210.6%FY 2024: -555.8%FY 2025: -891.3%
FY 2018 5y median -344.4% FY 2025
Net Margin -794.4%
FY 2018: 0.0%FY 2019: -1407.4%FY 2020: -134.0%FY 2021: -137.6%FY 2022: -330.6%FY 2023: -187.0%FY 2024: -475.6%FY 2025: -794.4%
FY 2018 5y median -330.6% FY 2025
ROE -19.7%
FY 2018: 62.3%FY 2019: 55.5%FY 2020: -16.1%FY 2021: -21.8%FY 2022: -31.6%FY 2023: -37.2%FY 2024: -26.8%FY 2025: -19.7%
FY 2018 5y median -26.8% FY 2025
ROIC -20.9%
FY 2018: -53.8%FY 2019: -49.4%FY 2020: -12.2%FY 2021: -19.4%FY 2022: -30.1%FY 2023: -33.3%FY 2024: -28.3%FY 2025: -20.9%
FY 2018 5y median -28.3% FY 2025
ROA -17.9%
FY 2018: -48.5%FY 2019: -35.4%FY 2020: -9.4%FY 2021: -16.5%FY 2022: -25.7%FY 2023: -25.5%FY 2024: -22.9%FY 2025: -17.9%
FY 2018 5y median -22.9% FY 2025

Growth (YoY)

Revenue -16.7%
FY 2018: 0.0%FY 2019: 0.0%FY 2020: 1060.0%FY 2021: 114.0%FY 2022: -35.7%FY 2023: 67.8%FY 2024: -40.1%FY 2025: -16.7%
FY 2018 FY 2025
Operating Income -33.5%
FY 2018: 0.0%FY 2019: -96.8%FY 2020: -9.7%FY 2021: -117.1%FY 2022: -60.4%FY 2023: -2.7%FY 2024: -58.1%FY 2025: -33.5%
FY 2018 FY 2025
EPS (diluted) -23.8%
FY 2018: 0.0%FY 2019: -93.8%FY 2020: -6.5%FY 2021: -111.1%FY 2022: -37.3%FY 2023: 12.2%FY 2024: -18.3%FY 2025: -23.8%
FY 2018 FY 2025
Free Cash Flow -13.0%
FY 2018: 0.0%FY 2019: 190.4%FY 2020: 354.9%FY 2021: -265.2%FY 2022: -19.4%FY 2023: 11.9%FY 2024: -51.0%FY 2025: -13.0%
FY 2018 FY 2025

Financial Health

Current Ratio 10.5×
FY 2018: 8.9×FY 2019: 2.7×FY 2020: 2.7×FY 2021: 4.9×FY 2022: 5.9×FY 2023: 4.7×FY 2024: 7.5×FY 2025: 10.5×
FY 2018 5y median 5.9× FY 2025
Quick Ratio 10.5×
FY 2018: 8.9×FY 2019: 2.7×FY 2020: 2.7×FY 2021: 4.9×FY 2022: 5.9×FY 2023: 4.7×FY 2024: 7.5×FY 2025: 10.5×
FY 2018 5y median 5.9× FY 2025
Debt / Equity 0.1×
FY 2018: -0.0×FY 2019: -0.3×FY 2020: 0.1×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.2×FY 2024: 0.1×FY 2025: 0.1×
FY 2018 5y median 0.1× FY 2025
Net Debt / EBITDA 0.9×
FY 2018: 1.9×FY 2019: 1.4×FY 2020: 0.3×FY 2021: 0.3×FY 2022: 0.3×FY 2023: 0.2×FY 2024: 0.2×FY 2025: 0.9×
FY 2018 5y median 0.3× FY 2025
Interest Coverage -1403×
FY 2018: -1341×FY 2019: -918×FY 2020: -403×FY 2021: -574×FY 2022: -916×FY 2023: -845×FY 2024: -1051×FY 2025: -1403×
FY 2018 5y median -916× FY 2025

Dividends

Dividend Yield 0.0%
FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2018 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2018 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31